Microfluidic hemophilia models using blood from healthy donors

BACKGROUND: Microfluidic clotting assays permit drug action studies for hemophilia therapeutics under flow. However, limited availability of patient samples and Inter‐donor variability limit the application of such assays, especially with many patients on prophylaxis. OBJECTIVE: To develop approache...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xinren, Panckeri, Karen A., Ivanciu, Lacramioara, Camire, Rodney M., Coxon, Carmen H., Cuker, Adam, Diamond, Scott L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Methodological Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971334/
https://www.ncbi.nlm.nih.gov/pubmed/31989085
http://dx.doi.org/10.1002/rth2.12286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971334/
https://www.ncbi.nlm.nih.gov/pubmed/31989085
http://dx.doi.org/10.1002/rth2.12286

Ejemplares similares